Smoking and tardive dyskinesia in male patients with chronic schizophrenia.

作者: Xiang Yang Zhang , Ya Qin Yu , Shilong Sun , Xuan Zhang , Wenjun Li

DOI: 10.1016/J.PNPBP.2011.06.006

关键词:

摘要: Interactions between smoking and movement disorders include the contrasting associations of more cigarette with reductions in Parkinson's disease increases tardive dyskinesia (TD) symptoms. Here we examine relationship TD a large sample inpatients schizophrenia. We used cross-sectional naturalistic methods to analyze prevalence severity neuroleptic-induced relation among 764 male chronic medicated meeting DSM-IV criteria for administered detailed questionnaire including general information, medical psychological conditions, behaviors. evaluated using abnormal involuntary scale (AIMS) psychopathology Positive Negative Syndrome Scale (PANSS). The main statistical analyses cross-tabulations by multivariate regression continuous measures (AIMS PANSS). found that did not significantly differ smokers (41%=237/578) non-smokers (37%=69/186). Secondary outcomes showed significant association AIMS total score age, duration illness hospitalization times. Thus, was associated Chinese schizophrenics, but consistent previous reports, older patients longer hospitalizations greater TD.

参考文章(48)
Siow-Ann Chong, Ene-Choo Tan, Chay Hoon Tan, Mythily, Smoking and tardive dyskinesia: lack of involvement of the CYP1A2 gene Journal of Psychiatry & Neuroscience. ,vol. 28, pp. 185- 189 ,(2003)
Stefano Pallanti, Wayne K. Goodman, Eric Hollander, A qualitative analysis of nonresponse: Management of treatment-refractory obsessive-compulsive disorder The Journal of Clinical Psychiatry. ,vol. 65, pp. 6- 10 ,(2004)
John M Kane, Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence. The Journal of Clinical Psychiatry. ,vol. 65, pp. 16- 20 ,(2004)
Chapman Ma, See Re, The consequences of long-term antipsychotic drug administration on basal ganglia neuronal function in laboratory animals. Critical Reviews in Neurobiology. ,vol. 8, pp. 85- 124 ,(1994)
Daniel Tarsy, Codrin Lungu, Ross J. Baldessarini, Epidemiology of tardive dyskinesia before and during the era of modern antipsychotic drugs Handbook of Clinical Neurology. ,vol. 100, pp. 601- 616 ,(2011) , 10.1016/B978-0-444-52014-2.00043-4
Dilip V. Jeste, Tardive dyskinesia in older patients. The Journal of Clinical Psychiatry. ,vol. 61, pp. 27- 32 ,(2000)
Débora Pastore Bassitt, Mário Rodrigues Louzã Neto, None, Clozapine efficacy in tardive dyskinesia in schizophrenic patients. European Archives of Psychiatry and Clinical Neuroscience. ,vol. 248, pp. 209- 211 ,(1998) , 10.1007/S004060050039
Christoph U Correll, Eva M Schenk, Tardive dyskinesia and new antipsychotics. Current Opinion in Psychiatry. ,vol. 21, pp. 151- 156 ,(2008) , 10.1097/YCO.0B013E3282F53132
Sing Lee, Wan-jun Guo, Adley Tsang, Yue-qin Huang, Yan-ling He, Ronald C. Kessler, Prevalence and correlates of active and ever-smokers in metropolitan China. Addictive Behaviors. ,vol. 34, pp. 969- 972 ,(2009) , 10.1016/J.ADDBEH.2009.05.005